TrialJCO precision oncology2024

Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab.

Alberto Hernando-Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.